These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27042729)

  • 21. Photocontact allergy due to thiocolchicoside.
    Foti C; Vena GA; Angelini G
    Contact Dermatitis; 1992 Sep; 27(3):201-2. PubMed ID: 1451479
    [No Abstract]   [Full Text] [Related]  

  • 22. Epileptogenic activity of thiocolchicoside.
    Sechi GP; Sechi MM
    Br J Clin Pharmacol; 2022 Nov; 88(11):4956-4957. PubMed ID: 36038125
    [No Abstract]   [Full Text] [Related]  

  • 23. Occupational allergic contact dermatitis from thiocolchicoside.
    Mancuso G; Berdondini RM
    Contact Dermatitis; 2000 Sep; 43(3):180-1. PubMed ID: 10985643
    [No Abstract]   [Full Text] [Related]  

  • 24. Skin atrophy caused by thiocolchicoside injections.
    Guarneri F; Guarneri C; Cannavò SP
    Int J Dermatol; 2006 Dec; 45(12):1473-4. PubMed ID: 17184273
    [No Abstract]   [Full Text] [Related]  

  • 25. Embolia cutis medicamentosa following thiocolchicoside injection.
    Guarneri C; Polimeni G; Guarneri F; Cuzzocrea S
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1005-6. PubMed ID: 18070022
    [No Abstract]   [Full Text] [Related]  

  • 26. Benzodiazepine withdrawal syndrome induced by thiocolchicoside.
    Lepelley M; Mallaret M
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):291-292. PubMed ID: 28108061
    [No Abstract]   [Full Text] [Related]  

  • 27. Penetration and distribution of thiocolchicoside through human skin: comparison between a commercial foam (Miotens) and a drug solution.
    Aguzzi C; Rossi S; Bagnasco M; Lanata L; Sandri G; Bona F; Ferrari F; Bonferoni MC; Caramella C
    AAPS PharmSciTech; 2008; 9(4):1185-90. PubMed ID: 19051040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epileptic seizure after treatment with thiocolchicoside.
    Giavina-Bianchi P; Giavina-Bianchi M; Tanno LK; Ensina LF; Motta AA; Kalil J
    Ther Clin Risk Manag; 2009 Jun; 5(3):635-7. PubMed ID: 19707540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A rare cause of cyanosis: Sulphaemoglobinaemia related to thiocolchicoside (Miorel)].
    Dupouy J; Petureau F; Montastruc JL; Oustric S; Degano B
    Rev Mal Respir; 2010; 27(1):80-3. PubMed ID: 20146957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study.
    Ketenci A; Basat H; Esmaeilzadeh S
    Agri; 2009 Jul; 21(3):95-103. PubMed ID: 19780000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemical-physical compatibility of thiocolchicoside and nonsteroidal anti-inflammatory drugs].
    Pifferi G
    Boll Chim Farm; 1993 Jun; 132(6):203-9. PubMed ID: 8398054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European pharmacovigilance: increasingly outsourced to drug companies.
    Prescrire Int; 2014 Dec; 23(155):302-3, 305-7. PubMed ID: 25629153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system.
    Carta M; Murru L; Botta P; Talani G; Sechi G; De Riu P; Sanna E; Biggio G
    Neuropharmacology; 2006 Sep; 51(4):805-15. PubMed ID: 16806306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spectrophometric characteristics of colchicine, colchicoside & thiocolchicoside, a significant derivative of recent use in neurology].
    GHIELMETTI G; BOCCHIA A
    Farmaco Prat; 1958 May; 13(5):256-61. PubMed ID: 13548146
    [No Abstract]   [Full Text] [Related]  

  • 35. Visual Hallucinations After Treatment With Thiocolchicoside.
    Martinho SM; Martins JT; Poças AL; Pereira JM; Neves A; Sousa JPC
    Prim Care Companion CNS Disord; 2020 Oct; 22(5):. PubMed ID: 33002352
    [No Abstract]   [Full Text] [Related]  

  • 36. Temporary Seizure in an Infant Who Had Been Exposed to G-Amino Butyric Acid Receptor Antagonist Thiocolchicoside.
    Havali C; Gucuyener K; Gurkas E; Demir E
    Pediatr Emerg Care; 2019 May; 35(5):e96-e97. PubMed ID: 28486264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyolysis in a patient treated with colchicine and atorvastatin.
    Tufan A; Dede DS; Cavus S; Altintas ND; Iskit AB; Topeli A
    Ann Pharmacother; 2006; 40(7-8):1466-9. PubMed ID: 16772404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of initial trials in psychiatry using thiocolchicoside (coltramyl)].
    CENAC-THALY H; DIDON T; ROBERT R
    Ann Med Psychol (Paris); 1959 Feb; 117(2):389-95. PubMed ID: 13627618
    [No Abstract]   [Full Text] [Related]  

  • 39. [New peculiar derivative of colchicine, thiocolchicoside (R.271): its decontracturing action in neurology].
    PLUVINAGE R; LEMOINE D; GROS H
    Sem Hop; 1957 Oct; 33(61):3602-7. PubMed ID: 13495531
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of thiocolchicoside or R. 271 in several rheumatic disorders].
    GAUCHER M; SOUPLET P
    Sem Hop; 1957 Nov; 33(63):3707-11. PubMed ID: 13495542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.